Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis
Clinical trial NCT01970488 · COMPLETED
Trial details
- NCT number
- NCT01970488
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-18
- Primary completion
- 2014-08-14
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.